Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Quick Links

Call customer care

Indications, safety, and warnings

Ureteral Stents

Brief Summary Document - HCP

Products

Contour™ Ureteral Stents:  IFU 51413322-01A

Percuflex™ Plus Ureteral Stent:  IFU 51413322-01A

Percuflex™ Ureteral Stent:  IFU 51413322-01A

Polaris™ Ultra Ureteral Stent:  IFU 51413322-01A


Rx statement

CAUTION: Federal Law (USA) restricts this device to sale by or on the order of a physician.

This device is restricted to use by or under the supervision of physicians trained in endoscopic urological biopsy procedures.

Prior to use, please refer to all applicable “Instructions for Use” for more information on Intended Use/Indications for Use, Contraindications, Warnings, Precautions, Potential Adverse Events, and Operator’s Instructions.

Intended use/Indications for use

The Ureteral Stents are intended to facilitate urinary drainage from the kidney to the bladder via placement endoscopically or fluoroscopically by a trained physician.

Contraindications

None known.

Warnings

None known.

Precautions

Not adhering to the following precautions could result in patient injury:

  • Retrieval line (suture) indwelling time should not exceed fourteen (14) days to avoid possible line encrustation.
  • Evaluate the stent periodically to ensure the stent is draining adequately and to observe for possible complications.
    • Note: Stent indwelling time (with retrieval line (suture) removed) should not exceed 365 days*.
    • Evaluate the stent on or before 90 days after placement, and at least every 90 days thereafter if long term use is indicated.
  • Formation of knots in Variable Length ureteral stents may occur. This may result in injury to the ureter during removal and/ or the need for additional surgical intervention. The presence of a knot should be considered if significant resistance is encountered during attempts at removal.

Refer to Instructions for Use for all applicable information on Precautions.

*Data on file.

Potential adverse events

Adverse events associated with retrograde or antegrade positioned indwelling ureteral stents include but are not limited to:

  • Allergic Reaction
  • Avulsion
  • Discomfort
  • Dislodgement
  • Edema
  • Encrustation
  • Erosion
  • Extravasation
  • Fistula
  • Hematoma
  • Hematuria
  • Hemorrhage
  • Hydronephrosis
  • Infection
    • Peritonitis
    • Sepsis
    • Urinary Tract Infection
  • Inflammation
  • Loss of Renal Function
  • Migration
  • Obstruction
  • Occlusion
  • Pain
  • Perforation
  • Reflux, Genitourinary (GU) (includes Ureteral Reflux)
  • Stone Formation
  • Tissue Damage
  • Unretrieved Device Fragment
  • Urinary Symptoms
    • Dysuria
    • Frequency
    • Incontinence
    • Nocturia
    • Urgency

Adverse events may require additional medical or surgical intervention.